1. Introduction
The ductus arteriosus is the fetal vascular communication between the pulmonary arterial circulation and the descending thoracic aorta. Following birth, increased arterial oxygen tension and withdrawal of placental prostaglandin exposure promote functional ductal constriction. In a structurally normal heart, closure redirects right ventricular output through the lungs and establishes separate systemic and pulmonary circuits. In selected congenital heart lesions, however, ductal closure eliminates a critical source of blood flow and can precipitate catastrophic decompensation [1,2].
Ductal-dependent circulation is best classified according to the physiologic function of the ductus: maintaining pulmonary blood flow, maintaining systemic blood flow, or improving intercirculatory mixing. The direction of ductal shunting reflects anatomy, relative vascular resistances, and ventricular outflow obstruction; it is not determined by the diagnosis alone.
2. Pulmonary Ductal Dependence
2.1 Anatomy and representative lesions
Pulmonary ductal dependence develops when severe obstruction or atresia prevents sufficient antegrade ventricular outflow to the pulmonary arteries. In this setting, the pulmonary vascular bed receives all or a substantial proportion of its supply from the aorta through the ductus:
Aorta → ductus arteriosus → pulmonary arteries → pulmonary veins → atrium.
Representative lesions include pulmonary atresia with intact ventricular septum (PA/IVS), pulmonary atresia with ventricular septal defect, critical pulmonary valve stenosis, severe tetralogy of Fallot with right ventricular outflow tract obstruction, and selected forms of double-outlet right ventricle or d-transposition with pulmonary outflow obstruction [2,3].
The degree of ductal dependence is variable. In critical pulmonary stenosis, residual antegrade flow may coexist with ductal flow, whereas in true pulmonary atresia there is no direct right ventricular egress through the pulmonary valve. In pulmonary atresia with VSD and major aortopulmonary collateral arteries, pulmonary blood supply may also be provided by collaterals, and complete ductal dependence should not be assumed.
2.2 Hemodynamics and deterioration
During neonatal transition, declining pulmonary vascular resistance favors flow from the aorta into the pulmonary arteries when a ductal connection is available. The magnitude and distribution of flow depend on ductal caliber, its origin and insertion, pulmonary arterial anatomy, systemic arterial pressure, and pulmonary vascular resistance.
Progressive ductal constriction reduces effective pulmonary blood flow and pulmonary venous return, causing worsening arterial desaturation, cyanosis, and potentially metabolic acidosis. If nearly all pulmonary flow is ductal, abrupt closure can be rapidly fatal.
A widely patent ductus, however, is not invariably benign. Excessive aorta-to-pulmonary flow can increase pulmonary venous return and ventricular preload while reducing systemic diastolic pressure. Thus, the aim is adequate, balanced pulmonary flow, not the highest achievable oxygen saturation. The extent of ventricular volume loading depends on intracardiac communications and ventricular physiology, and cannot be generalized across all pulmonary ductal-dependent lesions.
2.3 Imaging and procedural implications
Echocardiography should identify the precise level of pulmonary outflow obstruction, ventricular and valve morphology, size and continuity of the branch pulmonary arteries, sources of pulmonary flow, associated septal communications, and the ductal course and restriction. CT angiography or catheterization may be particularly valuable when ductal tortuosity, branch pulmonary artery discontinuity, or major aortopulmonary collateral arteries complicate planning.
Management options include catheter-based pulmonary valvotomy for suitable critical pulmonary stenosis, RV outflow perforation and valvotomy in selected PA/IVS anatomies, ductal stenting, surgical systemic-to-pulmonary shunting, and early definitive repair where appropriate. In PA/IVS, coronary sinusoids and possible right-ventricle-dependent coronary circulation must be evaluated before any strategy that decompresses the right ventricle.
Ductal stenting and surgical shunting are alternative strategies for maintaining pulmonary flow. Comparative studies and meta-analyses generally support ductal stenting as an effective option in selected anatomy, but selection is influenced by ductal origin, tortuosity, branch pulmonary artery stenosis, expected duration of palliation, and local procedural expertise [8].
3. Systemic Ductal Dependence
3.1 Anatomy and representative lesions
Systemic ductal dependence occurs when the left heart, aortic valve, or aortic arch cannot supply adequate systemic output. The ductus provides a pathway by which the right ventricle supplies part or most of the systemic circulation through the pulmonary artery:
Right ventricle → pulmonary artery → ductus arteriosus → descending aorta → systemic organs.
Typical lesions include hypoplastic left heart syndrome (HLHS), interrupted aortic arch, critical coarctation, and selected cases of critical aortic stenosis with severe left ventricular dysfunction [2,4].
In HLHS with aortic atresia, the right ventricle supplies the pulmonary and systemic circulations in parallel. Ductal blood enters the descending aorta, while the ascending aorta and coronary arteries may be perfused retrogradely through a hypoplastic transverse arch. This configuration emphasizes why ductal caliber and arch anatomy jointly determine cerebral and coronary perfusion.
In critical coarctation and interrupted aortic arch, the proximal aorta may continue to support the upper body while ductal flow supplies the descending aorta. The exact territories at risk depend on the location of the obstruction relative to the head and neck vessels.
3.2 Hemodynamics and deterioration
As the ductus narrows, blood delivery to the lower body declines, leading to weak femoral pulses, differential blood pressure, oliguria, poor perfusion, hyperlactatemia, metabolic acidosis, and progressive shock. In HLHS, loss of ductal supply may additionally compromise cerebral and coronary perfusion.
A misleading feature is that systemic oxygen saturation can remain relatively high or may even increase while systemic blood flow deteriorates. The more useful physiologic question is whether total cardiac output is adequately apportioned between the pulmonary and systemic vascular beds.
For a common ventricular or right ventricular source of output, the Qp/Qs balance is particularly sensitive to changes in pulmonary vascular resistance and systemic vascular resistance. Excess pulmonary flow can decrease effective systemic delivery, particularly during the normal postnatal fall in pulmonary vascular resistance. In HLHS, excessive oxygen administration or unnecessary hyperventilation can accentuate pulmonary overcirculation under some circumstances [4,5].
The often-cited saturation range used in preoperative HLHS care is a contextual surrogate rather than a universal treatment target. Diastolic pressure, perfusion examination, urine output, lactate trend, acid-base status, and echocardiographic assessment must guide management alongside saturation.
3.3 Diagnostic assessment and therapeutic pathways
Echocardiographic assessment includes aortic and mitral valve anatomy, ventricular size and function, aortic arch continuity, ductal insertion and flow direction, atrial septal patency, and coronary perfusion concerns. A restrictive or intact atrial septum in HLHS creates an additional emergency: pulmonary venous hypertension and impaired oxygenation despite an open ductus.
Immediate stabilization requires restoration of ductal patency, appropriate respiratory and circulatory support, and timely selection of a definitive intervention. Options vary with morphology and include neonatal arch reconstruction, aortic valvotomy, staged Norwood-type palliation, hybrid bilateral pulmonary artery banding with ductal stenting, or selected transplant pathways. Restoring ductal patency is a bridge, not a substitute for correcting the systemic outflow obstruction.
4. Prostaglandin E₁: Physiologic Rationale and Clinical Use
4.1 Mechanism and indications
Prostaglandin E₁ (PGE₁; alprostadil) relaxes ductal smooth muscle and can maintain or restore ductal patency. Continuous intravenous infusion is the standard initial treatment when a ductal-dependent lesion is suspected, even before definitive anatomic characterization in an unstable neonate. Ductal responsiveness decreases with postnatal remodeling, so late reopening may be incomplete [1,2].
The immediate therapeutic endpoint differs by physiology. In pulmonary ductal dependence, improvement is commonly reflected by stabilization of oxygenation and pulmonary blood flow. In systemic ductal dependence, improved blood pressure, peripheral perfusion, metabolic status, and urine output may be more informative than oxygen saturation. In d-transposition without severe pulmonary outflow obstruction, PGE₁ may improve mixing but cannot replace adequate atrial communication when restrictive atrial septal physiology necessitates balloon atrial septostomy.
4.2 Dosing and response
Starting and maintenance doses vary by clinical urgency, ductal constriction, time from birth, and institutional protocol. Historical reports used higher initial doses, whereas observational neonatal cohorts support effective treatment at substantially lower maintenance infusions, sometimes around 0.005–0.02 micrograms/kg/min [3,6]. The minimum effective dose is generally preferred after stabilization.
Treatment should be assessed by both clinical response and echocardiographic ductal caliber and flow. Failure to improve may reflect a fully constricted or anatomically abnormal ductus, branch pulmonary artery abnormalities, intracardiac restriction, inadequate systemic output, or an incorrect physiologic diagnosis. Dose escalation alone does not resolve these alternative mechanisms.
4.3 Adverse effects and monitoring
Important PGE₁-associated adverse effects include apnea, hypotension, fever or flushing, edema, and gastrointestinal intolerance. Bradycardia, irritability, and seizures have also been described. Apnea can occur even at low doses and is particularly consequential during interfacility transport, making airway preparedness and continuous monitoring essential [3,6,7].
Clinical surveillance should include respiratory pattern, heart rate, blood pressure, temperature, perfusion, fluid balance, urine output, and serial metabolic evaluation. Not every infant receiving PGE₁ requires routine intubation, but the threshold for airway support must reflect clinical status, dosing, transport circumstances, and institutional resources.
The evidence supporting PGE₁ is predominantly observational. A Cochrane systematic review did not identify eligible randomized controlled trials; its absence of randomized evidence should not be interpreted as evidence of clinical ineffectiveness [1].
5. Ductal Patency and the Trade-Off Between Qp and Qs
The three teaching diagrams highlight a central principle: ductal patency preserves an essential route of circulation but does not ensure an appropriate distribution of cardiac output.
In ductal-dependent pulmonary circulation, falling pulmonary vascular resistance may increase aortic runoff through the ductus. Depending on ventricular and intracardiac anatomy, this can produce pulmonary overcirculation, increased pulmonary venous return, ventricular volume loading, reduced systemic diastolic pressure, and diminished end-organ perfusion. Mesenteric hypoperfusion may contribute to intestinal injury in vulnerable neonates, but necrotizing enterocolitis is multifactorial and should not be attributed solely to PGE₁ or to ductal runoff.
In systemic ductal dependence, excessive pulmonary flow competes directly with systemic output, especially in parallel-circulation physiology such as HLHS. Systemic perfusion can deteriorate despite improved pulse oximetry. In both groups, management requires coordinated adjustment of respiratory conditions, hemoglobin and oxygen delivery, vasoactive treatment, volume status, and timing of intervention. There is no universally appropriate inspired oxygen fraction or saturation threshold across all ductal-dependent lesions.
6. Key Clinical Principles
- Identify the circulation being supported. The ductus may supply the lungs, the systemic circulation, or additional intercirculatory mixing.
- Interpret flow direction anatomically. Aorta-to-PA flow usually supports pulmonary perfusion; PA-to-aorta flow supports systemic perfusion, but direction and magnitude vary with vascular resistance and obstruction.
- Treat suspected ductal closure promptly. PGE₁ is initial stabilization while urgent anatomic and physiologic assessment proceeds.
- Do not equate saturation with perfusion. Oxygenation may improve while systemic oxygen delivery deteriorates.
- Monitor PGE₁ toxicity. Apnea and hypotension require particular attention, especially during transport.
- Assess the entire circulation. Ductal anatomy, atrial communication, branch pulmonary arteries, ventricular function, and systemic obstruction determine definitive management.
- Plan definitive palliation early. Ductal preservation provides time for catheter or surgical treatment rather than an enduring solution.
References
[1] Akkinapally S, Hundalani SG, Kulkarni M, et al. Prostaglandin E1 for maintaining ductal patency in neonates with ductal-dependent cardiac lesions. Cochrane Database Syst Rev. 2018. DOI: 10.1002/14651858.CD011417.pub2. PMID: 29486048.
[2] Connor JA, Thiagarajan R. Hypoplastic left heart syndrome. Orphanet J Rare Dis. 2007;2:23. DOI: 10.1186/1750-1172-2-23. PMID: 17498282.
[3] Reddy SC, Saxena A. Prostaglandin E1: First stage palliation in neonates with congenital cardiac defects. Indian J Pediatr. 1998. DOI: 10.1007/BF02752297. PMID: 10771966.
[4] Graham EM, Bradley SM, Atz AM. Preoperative management of hypoplastic left heart syndrome. Expert Opin Pharmacother. 2005. DOI: 10.1517/14656566.6.5.687. PMID: 15934895.
[5] Jobes DR, Nicolson SC, Steven JM. Carbon dioxide prevents pulmonary overcirculation in hypoplastic left heart syndrome. Ann Thorac Surg. 1992. DOI: 10.1016/0003-4975(92)91166-7. PMID: 1610228.
[6] Kramer HH, Sommer M, Rammos S, Krogmann O. Evaluation of low dose prostaglandin E1 treatment for ductus dependent congenital heart disease. Eur J Pediatr. 1995. DOI: 10.1007/BF02276712. PMID: 8582419.
[7] Cucerea M, Simon M, Moldovan E, et al. Congenital heart disease requiring maintenance of ductus arteriosus in critically ill newborns admitted at a tertiary neonatal intensive care unit. J Crit Care Med. 2016. DOI: 10.1515/jccm-2016-0031. PMID: 29967858.
[8] Li DX, Zhou X, Li MS, et al. Arterial duct stent versus surgical shunt for patients with duct-dependent pulmonary circulation: a meta-analysis. BMC Cardiovasc Disord. 2021. DOI: 10.1186/s12872-020-01817-2. PMID: 33407150.